Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of the Effects of Pravastatin on Cholesterol Levels, Inflammation and Cognition in Schizophrenia

NCT01082588 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01082588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01082588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of the Effects of Pravastatin on Cholesterol Levels, Inflammation and Cognition in Schizophrenia
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
September 30, 2012
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorders, schizophrenia, schizophreniform disorders